NICE guideline NG215 recommends sleep hygiene measures and Cognitive Behavioural Therapy for Insomnia (CBT-I) as first-line treatments for persistent insomnia
Beyond these established indications, accumulating evidence suggests that GLP-1 RAs exert pleiotropic effects on immune regulation, inflammation, and tissue remodelingpathways highly relevant to dermatological and surgical disciplines [1,2,3,4,5]
In terms of safety, tesofensine was well tolerated with a low incidence of adverse events similar to the placebo group
By directly activating IGF-1 receptors, it influences downstream anabolic cascades involved in protein synthesis and cellular growth
Semaglutides appetite-suppressing quality means the typical patient will consume fewer calories
While assessing BMI is an important first step, treatment decisions always involve thorough discussions with each patient to ensure that recommended therapies align with their unique health needs, goals, and preferences